57.100
|
NHSN Registration Form
|
No change
|
Addition of
question to indicate facility type.
|
The
facility type question was added to allow tracking of the
facility types completing the NHSN enrollment process.
This change does not
affect the estimated burden of this form.
|
57.101
|
Facility Contact
Information
|
No change
|
No changes
|
N/A
|
57.103
|
Patient Safety
Component-Annual Hospital Survey
|
No change
|
Removal
of Question #2.
Removal
of select pathogens from Question #3.
Updates
to Question #10.
New
response option for Question #12.
New
question #15 was added.
Minor
adjustments to language in Questions 16-19.
Minor
adjustments to Questions #20 – 22, 24, 26, 28, 35.
Update
to the wording of Question 23.
Removal of
Question #33.
|
This
information was deemed no longer necessary and was not providing
us with useful information anymore.
Testing
methods did not vary widely between organisms based on earlier
data collected in this survey. It was therefore decided that
this question only needs to be asked for one gram negative and
one gram positive organism to help reduce burden.
Antibiotic
resistance testing of Candida usually varies by organism
species. Therefore, to truly understand the practices in
facilities with regards to Candida testing, the question needs
to be asked separately for the different species of Candida.
After discussion with relevant staff members, this information
should be easy to capture in facilities answering this survey.
A
new test type choice of “NAAT plus EIA, if NAAT positive”
was added to account for a shift in CDI testing practices used
by hospitals, and allow for appropriate risk-adjustment of CDI
in these hospitals.
The
purpose of this question is to understand the infrastructure
supporting infection control programs in facilities. By only
including questions about infection preventionists, last year’s
survey did not adequately capture the infrastructure and
resources designated to infection control in each facility.
Adjusting
the questions for clarity, and to specify these questions apply
to policies in the facilities. This will allow better alignment
with the survey questions and how DHQP will interpret the
information from these questions.
Small
language edits were made for clarity and to better represent the
intent of the questions.
The
question has been updated to reflect current practice and to
help reduce confusion with the previous version of this
question.
This
change will allow us to incorporate logic and only ask 33b to
those facilities where it is relevant. Additional answer
categories added to allow us to collect more detailed
information on the type of feedback given to prescribers, which
will be used to inform national estimates of the presence of
stewardship programs. This changes removes ambiguity that was
present in the previous versions of these questions.
These
changes result in an increase of 417 burden hours for this form.
|
57.105
|
Group Contact Information
|
No change
|
No changes
|
N/A
|
57.106
|
Patient Safety Monthly
Reporting Plan
|
No change
|
No changes
|
N/A
|
57.108
|
Primary Bloodstream
Infection (BSI)
|
No change
|
Response
options were updated to change the wording from “culture”
to organisms identified from “specimens.”
|
This
change will better reflect newer non-culture diagnostic tests
that may be used to identify the presence of organisms.
This change does not
affect the estimated burden of this form.
|
57.111
|
Pneumonia (PNEU)
|
No change
|
Response
options were updated to change the wording from “culture”
to organisms identified from “specimens.”
Added
bronchoalveolar lavage (BAL), protected specimen brushing, and
endotracheal aspirates to the form.
|
This
change will better reflect newer non-culture diagnostic tests
that may be used to identify the presence of organisms.
Added
bronchoalveolar lavage (BAL), protected specimen brushing, and
endotracheal aspirates to the form to reflect that these are
also legitimate specimen sites used to diagnosis pneumonia in
certain circumstances.
These changes do not
affect the estimated burden of this form.
|
57.112
|
Ventilator-Associated
Event
|
No change
|
Response
options were updated to change the wording from “culture”
to organisms identified from “specimens.”
|
This
change will better reflect newer non-culture diagnostic tests
that may be used to identify the presence of organisms.
This change does not
affect the estimated burden of this form.
|
57.113
|
Pediatric
Ventilator-Associated Event (PedVAE)
|
N/A. This is a new
form.
|
A new form is being added
as part of the NHSN Patient Safety Component.
|
The NHSN PedVAE Form was
developed amid increasing interest in the public health impact of
conditions and complications in mechanically-ventilated neonates
and children in acute care hospitals, long term acute care
hospitals, and inpatient rehabilitation facilities. PedVAE
surveillance will extend NHSN’s current VAE surveillance to
pediatric populations (currently, VAE surveillance is only
conducted in adult locations). PedVAE surveillance will provide a
standardized, evidence-based surveillance method for identifying
and tracking incidence and outcomes of ventilator-associated
conditions in children in US healthcare facilities. These data
may be used by facilities to identify areas where prevention and
patient safety efforts may be improved.
This
new form will add a total of 100,000 burden hours to the ICR.
|
57.114
|
Urinary Tract Infection
(UTI)
|
No change
|
Response
options were updated to change the wording from “culture”
to organisms identified from “specimens.”
|
This
change will better reflect newer non-culture diagnostic tests
that may be used to identify the presence of organisms.
This change does not
affect the estimated burden of this form.
|
57.115
|
Custom Event
|
N/A. This is a new
form.
|
A new form is being added
as part of the NHSN Patient Safety Component.
|
The NHSN Custom Event Form
for reporting of healthcare-associated infections other than
CLABSI, CAUTI, VAP, VAE, and SSI was developed amid increasing
interest in the public health impact of infections in acute care
hospitals, long term acute care hospitals, and inpatient
rehabilitation facilities. The Custom Event Form is used by
healthcare facilities as part of a standardized, evidence-based
surveillance method for identifying and tracking incidence and
outcomes of healthcare-associated infections in US healthcare
facilities. These data may be used by facilities to identify
areas where prevention of healthcare-associated infections may be
improved.
This new form will add
a total of 106,167 burden hours to the ICR.
|
57.116
|
Denominators for Neonatal
Intensive Care Unit (NICU)
|
No change
|
No changes
|
N/A
|
57.117
|
Denominators for Specialty
Care Area (SCA)/Oncology (ONC)
|
No change
|
No changes
|
N/A
|
57.118
|
Denominators for Intensive
Care Unit (ICU)/Other Locations (Not NICU or SCA)
|
No change
|
No changes
|
N/A
|
57.120
|
Surgical Site Infection
(SSI)
|
No change
|
Response
options were updated to change the wording from “culture”
to organisms identified from “specimens.”
|
This
change will better reflect newer non-culture diagnostic tests
that may be used to identify the presence of organisms.
This change does not
affect the estimated burden of this form.
|
57.121
|
Denominator for Procedure
|
No change
|
The time
estimate for completion of this form was updated to 10 minutes
per response.
|
The
time estimate for completion of this form was updated from 5
minutes to 10 minutes to account for facilities completing this
surveillance without access to electronic methods of data
submission.
This
change results in an increase in 270,000 burden hours for this
form.
|
57.123
|
Antimicrobial Use and
Resistance (AUR)-Microbiology Data Electronic Upload
Specification Tables
|
No change
|
No changes
|
N/A
|
57.124
|
Antimicrobial Use and
Resistance (AUR)-Pharmacy Data Electronic Upload Specification
Tables
|
No change
|
No changes
|
N/A
|
57.125
|
Central Line Insertion
Practices Adherence Monitoring
|
No change
|
No changes
|
N/A
|
57.126
|
MDRO or CDI Infection Form
|
No change
|
Response
options were updated to change the wording from “culture”
to organisms identified from “specimens.”
|
This
change will better reflect newer non-culture diagnostic tests
that may be used to identify the presence of organisms.
This change does not
affect the estimated burden of this form.
|
57.127
|
MDRO and CDI Prevention
Process and Outcome Measures Monthly Monitoring
|
No change
|
New response
option was added for CDI test type.
|
A
new test type choice of “NAAT plus EIA, if NAAT positive”
was added to account for a shift in CDI testing practices used
by hospitals, and allow for appropriate risk-adjustment of CDI
in these hospitals.
This change does not
affect the estimated burden of this form.
|
57.128
|
Laboratory-identified MDRO
or CDI Event
|
No change
|
No changes
|
N/A
|
57.129
|
Adult Sepsis
|
N/A. This is a new
form.
|
A new form is being added
as part of the NHSN Patient Safety Component.
|
The NHSN Adult Sepsis
Module was developed amid increasing interest in the public
health impact of sepsis. The Adult Sepsis module provides a
standardized, evidence-based surveillance method for identifying
and tracking incidence and outcomes of sepsis among adults in US
healthcare facilities. These data may be used by facilities to
identify areas where sepsis management may be improved. Data may
also be used by public health authorities to identify regions and
facilities with poor sepsis outcomes and target interventions
accordingly.
This new form will add
a total of 5,208 burden hours to the ICR.
|
57.137
|
Long-Term Care Facility
Component – Annual Facility Survey
|
No change
|
The
National Provider ID was added.
New
response option was added for CDI test type.
Minor
adjustments to language in Questions 6-9.
Three
questions were added to the antimicrobial stewardship section.
The number of
respondents was increased to 350.
|
The
National Provider ID was added to the 2017 annual survey to
accommodate the potential for future CMS reporting and data
analysis requirements.
A
new test type choice of “NAAT plus EIA, if NAAT positive”
was added to account for a shift in CDI testing practices used
by facilities, and allow for appropriate risk-adjustment of CDI
in these facilities.
Adjusting
the questions for clarity, and to specify these questions apply
to policies in the facilities. This will allow better alignment
with the survey questions and how DHQP will interpret the
information from these questions.
Three
additional antibiotic stewardship questions added to align with
the LTCF core elements of antibiotic stewardship.
The
number of respondents was increased from 250 to 350 to account
for the increase in LTCF facilities using the NHSN LTCF
Component.
These changes result in
an increase of 128 burden hours for this form.
|
57.138
|
Laboratory-identified MDRO
or CDI Event for LTCF
|
No change
|
The number of
respondents was increased to 350.
|
The
number of respondents was increased from 250 to 350 to account
for the increase in LTCF facilities using the NHSN LTCF
Component.
This change results in
an increase of 550 burden hours for this form.
|
57.139
|
MDRO and CDI LabID Event
Reporting Monthly Summary Data for LTCF
|
MDRO and CDI Prevention
Process Measures Monthly Monitoring for LTCF
|
Form
was renamed.
New
question was added.
Row
for “report no events” was added.
The number of
respondents was increased to 350.
|
Form
was renamed to more accurately reflect the data captured on it.
A
new question was added to assess the number of admissions on C.
difficile
treatment.
A
row was added to check the ‘report no events’ box
for the appropriate surveillance type to allow for complete
reporting of data on one form.
The
number of respondents was increased from 250 to 350 to account
for the increase in LTCF facilities using the NHSN LTCF
Component.
These changes result in
an increase of 450 burden hours for this form.
|
57.140
|
Urinary Tract Infection
(UTI) for LTCF
|
No change
|
The number of
respondents was increased to 350.
|
The
number of respondents was increased from 250 to 350 to account
for the increase in LTCF facilities using the NHSN LTCF
Component.
This change results in
an increase of 1,325 burden hours for this form.
|
57.141
|
Monthly Reporting Plan for
LTCF
|
No change
|
The number of
respondents was increased to 350.
|
The
number of respondents was increased from 250 to 350 to account
for the increase in LTCF facilities using the NHSN LTCF
Component.
This change results in
an increase of 100 burden hours for this form.
|
57.142
|
Denominators for LTCF
Locations
|
No change
|
New
question was added.
The number of
respondents was increased to 350.
|
A
new question was added to assess the number of urine cultures
ordered to describe ordering practices of NHSN LTCFs and
possibly for future risk adjustment.
The
number of respondents was increased from 250 to 350 to account
for the increase in LTCF facilities using the NHSN LTCF
Component.
These changes result in
an increase of 4,320 burden hours for this form.
|
57.143
|
Prevention Process
Measures Monthly Monitoring for LTCF
|
No change
|
The number of
respondents was increased to 300.
|
The
number of respondents was increased from 250 to 300 to account
for the increase in LTCF facilities using the NHSN LTCF
Component.
This change results in
an increase of 50 burden hours for this form.
|
57.150
|
Patient Safety Component-
Annual Facility Survey for LTAC
|
No change
|
Removal
of Question #2.
Removal
of select pathogens from Question #3.
Updates
to Question #10.
New
response option for Question #12.
New
question #15 was added.
Minor
adjustments to language in Questions 16-19.
Minor
adjustments to Questions #20 – 22, 24, 26, 28, 35.
Update
to the wording of Question 23.
Removal of
Question #33.
|
This
information was deemed no longer necessary and was not providing
us with useful information anymore.
Testing
methods did not vary widely between organisms based on earlier
data collected in this survey. It was therefore decided that
this question only needs to be asked for one gram negative and
one gram positive organism to help reduce burden.
Antibiotic
resistance testing of Candida usually varies by organism
species. Therefore, to truly understand the practices in
facilities with regards to Candida testing, the question needs
to be asked separately for the different species of Candida.
After discussion with relevant staff members, this information
should be easy to capture in facilities answering this survey.
A
new test type choice of “NAAT plus EIA, if NAAT positive”
was added to account for a shift in CDI testing practices used
by hospitals, and allow for appropriate risk-adjustment of CDI
in these hospitals.
The
purpose of this question is to understand the infrastructure
supporting infection control programs in facilities. By only
including questions about infection preventionists, last year’s
survey did not adequately capture the infrastructure and
resources designated to infection control in each facility.
Adjusting
the questions for clarity, and to specify these questions apply
to policies in the facilities. This will allow better alignment
with the survey questions and how DHQP will interpret the
information from these questions.
Small
language edits were made for clarity and to better represent the
intent of the questions.
The
question has been updated to reflect current practice and to
help reduce confusion with the previous version of this
question.
This
change will allow us to incorporate logic and only ask 33b to
those facilities where it is relevant. Additional answer
categories added to allow us to collect more detailed
information on the type of feedback given to prescribers, which
will be used to inform national estimates of the presence of
stewardship programs. This changes removes ambiguity that was
present in the previous versions of these questions.
These
changes result in an increase of 33 burden hours for this form.
|
57.151
|
Patient Safety
Component-Annual Facility Survey for IRF
|
No change
|
Removal
of Question #2.
Removal
of select pathogens from Question #3.
Updates
to Question #10.
New
response option for Question #12.
New
question #15 was added.
Minor
adjustments to language in Questions 16-19.
Minor
adjustments to Questions #20 – 22, 24, 26, 28, 35.
Update
to the wording of Question 23.
Removal of
Question #33.
|
This
information was deemed no longer necessary and was not providing
us with useful information anymore.
Testing
methods did not vary widely between organisms based on earlier
data collected in this survey. It was therefore decided that
this question only needs to be asked for one gram negative and
one gram positive organism to help reduce burden.
Antibiotic
resistance testing of Candida usually varies by organism
species. Therefore, to truly understand the practices in
facilities with regards to Candida testing, the question needs
to be asked separately for the different species of Candida.
After discussion with relevant staff members, this information
should be easy to capture in facilities answering this survey.
A
new test type choice of “NAAT plus EIA, if NAAT positive”
was added to account for a shift in CDI testing practices used
by hospitals, and allow for appropriate risk-adjustment of CDI
in these hospitals.
The
purpose of this question is to understand the infrastructure
supporting infection control programs in facilities. By only
including questions about infection preventionists, last year’s
survey did not adequately capture the infrastructure and
resources designated to infection control in each facility.
Adjusting
the questions for clarity, and to specify these questions apply
to policies in the facilities. This will allow better alignment
with the survey questions and how DHQP will interpret the
information from these questions.
Small
language edits were made for clarity and to better represent the
intent of the questions.
The
question has been updated to reflect current practice and to
help reduce confusion with the previous version of this
question.
This
change will allow us to incorporate logic and only ask 33b to
those facilities where it is relevant. Additional answer
categories added to allow us to collect more detailed
information on the type of feedback given to prescribers, which
will be used to inform national estimates of the presence of
stewardship programs. This changes removes ambiguity that was
present in the previous versions of these questions.
These
changes result in an increase of 83 burden hours for this form.
|
57.200
|
Healthcare Personnel
Safety Component Annual Facility Survey
|
No change
|
No changes
|
N/A
|
57.203
|
Healthcare Personnel
Safety Monthly Reporting Plan
|
No change
|
No changes
|
N/A
|
57.204
|
Healthcare Worker
Demographic Data
|
No change
|
No changes
|
N/A
|
57.205
|
Exposure to Blood/Body
Fluids
|
No change
|
No changes
|
N/A
|
57.206
|
Healthcare Worker
Prophylaxis/Treatment
|
No change
|
No changes
|
N/A
|
57.207
|
Follow-Up Laboratory
Testing
|
No change
|
No changes
|
N/A
|
57.210
|
Healthcare Worker
Prophylaxis/Treatment-Influenza
|
No change
|
No changes
|
N/A
|
57.300
|
Hemovigilance Module
Annual Survey – Acute Care Facility
|
Hemovigilance Module
Annual Survey
|
The form name
was updated.
|
The
title change will allow facilities to identify which survey they
should complete. There is a new annual facility survey form for
non-acute care facilities.
This
change does not affect the estimated burden of this form.
|
57.301
|
Hemovigilance Module
Monthly Reporting Plan
|
No change
|
No changes
|
N/A
|
57.303
|
Hemovigilance Module
Monthly Reporting Denominators
|
No change
|
No changes
|
N/A
|
57.304
|
Hemovigilance Adverse
Reaction
|
No change
|
This form will
be removed from the package.
|
This
single form has been removed from the package and in its place
14 new forms have been added.
Removing
this form decreases the package burden by 6,000 burden hours.
|
57.305
|
Hemovigilance Incident
|
No change
|
No changes
|
N/A
|
57.306
|
Hemovigilance Module
Annual Survey - Non-Acute Care Facility
|
N/A. This is a new
form.
|
A new form is being added
as part of the NHSN Hemovigilance Component.
|
Non-acute care facilities
can now report to the NHSN Hemovigilance Module. All
participating facilities complete an Annual Facility Survey. This
new form contains questions specific to non-acute care
facilities. The inclusion of non-acute care facilities will
broaden the scope of facilities reporting to the Hemovigilance
Module. This will allow for more robust data collection to
identify emerging trends in transfusion related adverse events
among these facilities.
This new form will add
a total of 117 burden hours to the ICR.
|
57.307
|
Hemovigilance
Adverse Reaction - Acute Hemolytic Transfusion Reaction
|
N/A. These are new
forms.
|
New forms are being added
as part of the NHSN Hemovigilance Component.
|
The Adverse Reaction form
split into one general information form and 14 reaction-specific
forms to reduce the length of form. The General form includes
questions that will be answered by the majority of facilities and
only one reaction-specific form will be completed for each
general form. Splitting the form prevents facilities from reading
through questions that do not pertain to the transfusion reaction
they are submitting.
These new forms will
add a total of 5,205 burden hours to the ICR.
|
57.308
|
Hemovigilance
Adverse Reaction - Allergic Transfusion Reaction
|
57.309
|
Hemovigilance
Adverse Reaction - Delayed Hemolytic Transfusion Reaction
|
57.310
|
Hemovigilance
Adverse Reaction - Delayed Serologic Transfusion Reaction
|
57.311
|
Hemovigilance
Adverse Reaction - Febrile Non-hemolytic Transfusion Reaction
|
57.312
|
Hemovigilance
Adverse Reaction - Hypotensive Transfusion Reaction
|
57.313
|
Hemovigilance
Adverse Reaction - Infection
|
57.314
|
Hemovigilance
Adverse Reaction - Post Transfusion Purpura
|
57.315
|
Hemovigilance
Adverse Reaction - Transfusion Associated Dyspnea
|
57.316
|
Hemovigilance
Adverse Reaction - Transfusion Associated Graft vs. Host Disease
|
57.317
|
Hemovigilance
Adverse Reaction - Transfusion Related Acute Lung Injury
|
57.318
|
Hemovigilance
Adverse Reaction - Transfusion Associated Circulatory Overload
|
57.319
|
Hemovigilance
Adverse Reaction - Unknown Transfusion Reaction
|
57.320
|
Hemovigilance
Adverse Reaction - Other Transfusion Reaction
|
57.400
|
Patient Safety
Component—Annual Facility Survey for Ambulatory Surgery
Center (ASC)
|
No change
|
No changes
|
N/A
|
57.401
|
Outpatient Procedure
Component - Monthly Reporting Plan
|
No change
|
No changes
|
N/A
|
57.402
|
Outpatient Procedure
Component Event
|
No change
|
No changes
|
N/A
|
57.403
|
Outpatient Procedure
Component - Monthly Denominators and Summary
|
No change
|
No changes
|
N/A
|
57.500
|
Outpatient Dialysis Center
Practices Survey
|
No change
|
Reworded
Question #31.
Added
Questions 31a, 31c.
Added
Question #37.
Rewording
Questions 47-48.
Change response
options for Questions 48, 49bii, 50, 52.
|
Changed
“does your facility routinely test dialysate” to
instead ask “does your facility routinely test the
following” to expand data collection to include more than
just dialysate from the patient’s machine following a
pyrogenic reaction (i.e., see #31a and c).
Added
questions about whether the patient’s “a. blood”
or dialysis “c. water” are tested after a patient
has a pyrogenic reaction. These questions were added to gather
information on national practices about testing following
pyrogenic reactions.
Added
“What form of saline flush is most commonly used?”
to determine the national practice related to saline flushes.
Inserted
“rope-ladder” to clarify the questions pertain only
to those arteriovenous fistula and graft patients who do not
undergo buttonhole cannulation.
Changed
the current multiple choice option “sodium hypochlorite
solution” to “sodium hypochlorite solution without
alcohol” and added a new multiple choice option, “sodium
hypochlorite solution followed by alcohol” to determine
national practices related to application of sodium
hypochlorite.
These changes do not
affect the estimated burden of this form.
|
57.501
|
Dialysis Monthly Reporting
Plan
|
No change
|
No changes
|
N/A
|
57.502
|
Dialysis Event
|
No change
|
Added
a new question regarding blood cultures.
|
Added
a question: “If new antimicrobial start, was a blood
sample collected for culture?” to determine how often
intravenous (IV) antimicrobials are started without first
collecting a blood sample, which may lead to excessive and/or
inappropriate antimicrobial drug exposure for the patient. (The
blood sample is used to identify the pathogen causing the
infection and the pathogen’s antimicrobial drug
susceptibilities and effectively treat a bloodstream infection.)
Excessive and/or inappropriate use of antimicrobial drugs may
have poor treatment outcomes for the patient and contribute to
the development of multi-drug resistant organisms (MDROs).
This
change does not affect the estimated burden of this form.
|
57.503
|
Denominators for Dialysis
Event Surveillance
|
No change
|
Change the
question to assess the number of patients for whom dialyzers are
reused to required.
|
In
2015 the “Number of these patients for whom dialyzers are
reused” was added as an optional field because dialyzer
reuse has been identified as important risk factor for
infections. By including this field on both numerator and
denominator forms, it will be possible to calculate a dialyzer
reuse rate. This field will now become required for completion.
This change does not
affect the estimated burden of this form.
|
57.504
|
Prevention Process
Measures Monthly Monitoring for Dialysis
|
No change
|
No changes
|
N/A
|
57.505
|
Dialysis Patient Influenza
Vaccination
|
No change
|
No changes
|
N/A
|
57.506
|
Dialysis Patient Influenza
Vaccination Denominator
|
No change
|
No changes
|
N/A
|
57.507
|
Home Dialysis Center
Practices Survey
|
N/A. This is a new
form.
|
A new form is being added
as part of the NHSN Dialysis Component.
|
Dialysis centers that
provide training and support for patients who undergo
hemodialysis and/or peritoneal dialysis in their own homes have
different practices than centers that provide in-center
hemodialysis. The existing “Outpatient Dialysis Center
Practices Survey” was tailored to in-center hemodialysis
practices and could not be completed correctly by facilities that
do not offer that type of care. Therefore a new survey has been
created to collect information specific to facilities that
support home dialysis patients. Practice information being
collected includes:
Information
about the center’s affiliation, medical records systems,
and isolation practices
Patient
and staff census
Vaccination
practices
Hepatitis
screening practices
Practices
related to cannulation and cleaning of vascular accesses as well
as peritoneal catheters
This
new form will add a total of 250 burden hours to the ICR.
|